Cargando…
Skull defect increases the tumor treating fields strength without detrimental thermogenic effect: A computational simulating research
BACKGROUND: Tumor treating fields (TTFields) is an FDA‐approved adjuvant therapy for glioblastoma. The distribution of an applied electric field has been shown to be governed by distinct tissue structures and electrical conductivity. Of all the tissues the skull plays a significant role in modifying...
Autores principales: | Jin, Taian, Dou, Zhangqi, Zhao, Yu, Jiang, Biao, Xu, Jinghong, Zhang, Buyi, Wei, Boxing, Dong, Fei, Zhang, Jianmin, Sun, Chongran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883554/ https://www.ncbi.nlm.nih.gov/pubmed/35861406 http://dx.doi.org/10.1002/cam4.5037 |
Ejemplares similares
-
The dual role of the CD95 and CD95L signaling pathway in glioblastoma
por: Zhang, Yanrui, et al.
Publicado: (2022) -
Immune Checkpoint-Associated Locations of Diffuse Gliomas Comparing Pediatric With Adult Patients Based on Voxel-Wise Analysis
por: Zhang, Li, et al.
Publicado: (2021) -
Whether surgical resection or biopsy makes difference in single lesion primary central nervous system lymphoma: a single center retrospective cohort study
por: Cheng, Xin, et al.
Publicado: (2022) -
The Infratentorial Localization of Brain Metastases May Correlate with Specific Clinical Characteristics and Portend Worse Outcomes Based on Voxel-Wise Mapping
por: Dou, Zhangqi, et al.
Publicado: (2021) -
Mitochondria’s Role in the Maintenance of Cancer Stem Cells in Glioblastoma
por: Iranmanesh, Yasaman, et al.
Publicado: (2021)